HOME>Technology & Services>Reference

Reference

Reference

Nishimura M, Kohara J, Kuroda Y, Hiasa J, Tanaka S, Muroi Y, Kojima N, Furuoka H, Nishikawa Y. Oligomannose-coated liposome-entrapped dense granule protein 7induces protective immune response to Neospora caninum in cattle. Vaccine. 2013 Aug 2;31(35):3528-35.

Ishii M, Kojima N. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes. Int Immunopharmacol. 2013 Apr;15(4):685-92.
 
Kojima N, Ishii M, Kawauchi Y, Takagi H. Oligomannose-Coated Liposome as a Novel Adjuvant for the Induction of Cellular Immune Responses to Control Disease Status. Biomed Res Int. 2013;2013:562924.
 
Kawauchi Y, Kuroda Y, Kojima N. Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors. Glycoconj J. 2012 Oct;29(7):481-90.
 
Mizuuchi M, Hirohashi Y, Torigoe T, Kuroda T, Yasuda K, Shimizu Y, Saito T, Sato N. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses. Exp Mol Pathol. 2012 Feb;92(1):185-90.
 
Kozako T, Arima N, Yoshimitsu M, Honda SI, Soeda S. Liposomes and nanotechnology in drug development: focus on oncotargets. Int J Nanomedicine. 2012;7:4943-51.
 
Ishii M, Kato C, Hakamata A, Kojima N. Targeting with oligomannose-coated liposomes promotes maturation and splenic trafficking of dendritic cells in the peritoneal cavity. Int Immunopharmacol. 2011 Feb;11(2):164-71.
 
Kojima N, Kato C, Igarashi M, Ishii M. Development of peritoneal macrophage along a dendritic cell lineage in response to uptake of oligomannose-coated liposomes. Cell Immunol. 2011;271(2):335-41.
 
Kozako T, Hirata S, Shimizu Y, Satoh Y, Yoshimitsu M, White Y, Lemonnier F, Shimeno H, Soeda S, Arima N. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS J. 2011 Apr;278(8):1358-66.
 
Ishii M, Koyama A, Iseki H, Narumi H, Yokoyama N, Kojima N. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice. Int Immunopharmacol. 2010 Sep;10(9):1041-6.
 
Kato C, Kojima N. SIGNR1 ligation on murine peritoneal macrophages induces IL-12 production through NFkappaB activation. Glycoconj J. 2010 Jul;27(5):525-31.
 
Zhang H, Nishikawa Y, Yamagishi J, Zhou J, Ikehara Y, Kojima N, Yokoyama N, Xuan X. Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice. Exp Parasitol. 2010 Jun;125(2):130-6.
 
Ishii M, Kojima N. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization. Glycoconj J. 2010 Jan;27(1):115-23.
 
Nishikawa Y, Zhang H, Ikehara Y, Kojima N, Xuan X, Yokoyama N. Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clin Vaccine Immunol. 2009
 
Jun;16(6):792-7.
 
Takagi H, Numazaki M, Kajiwara T, Abe Y, Ishii M, Kato C, Kojima N. Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages. Glycobiology. 2009 Mar;19(3):258-66.
 
Abe Y, Kuroda Y, Kuboki N, Matsushita M, Yokoyama N, Kojima N. Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. J Biochem. 2008 Nov;144(5):563-70.
 
Kato C, Kajiwara T, Numazaki M, Takagi H, Kojima N. Oligomannose-coated liposomes activate ERK via Src kinases and PI3K/Akt in J774A.1 cells. Biochem Biophys Res Commun. 2008 Aug 8;372(4):898-901.
 
Kojima N, Biao L, Nakayama T, Ishii M, Ikehara Y, Tsujimura K. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. J Control Release. 2008 Jul 2;129(1):26-32.
 
Takagi H, Furuya N, Kojima N. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Cytokine. 2007 Dec;40(3):241-50.
 
Naruto H, Huang H, Nishikawa M, Kojima N, Mizuno A, Ohta K, Sakai Y. Feasibility of direct oxygenation of primary-cultured rat hepatocytes using polyethylene glycol-decorated liposome-encapsulated hemoglobin (LEH). J Biosci Bioeng. 2007 Oct;104(4):343-6.
 
Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T, Yokoyama N, Kojima N. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune
 
response in BALB/c mice through uptake by peritoneal macrophages. Parasite Immunol. 2007 May;29(5):229-39.
 
Ikehara Y, Kojima N. Development of a novel oligomannose-coated liposome-based anticancer drug-delivery system for intraperitoneal cancer. Curr Opin Mol Ther. 2007 Feb;9(1):53-61. Review.
 
Ikehara Y, Niwa T, Biao L, Ikehara SK, Ohashi N, Kobayashi T, Shimizu Y, Kojima N, Nakanishi H. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 2006 Sep 1;66(17):8740-8.
 
Kuboki N, Yokoyama N, Kojima N, Sakurai T, Inoue N, Sugimoto C. Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes. J Parasitol. 2006 Apr;92(2):389-93.
 
Shimizu Y, Yamakami K, Gomi T, Nakata M, Asanuma H, Tadakuma T, Kojima N. Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorg Med Chem. 2003 Apr 3;11(7):1191-5.